Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome
Article in Circulation Cardiovascular Quality and Outcomes (April 2021)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Circulation Cardiovascular Quality and Outcomes (April 2021)
Article in Acta Cardiologica (February 2020)
Article in La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine (November 2019)